| Note |
Risperdal. Original Risperidone. New presentation of 0.25 mg and 0.5mg. Maximum efficacy. Significant reduction of the most frequent symptoms in the elder: agitation, anxiety, aggressivity, apathy, verbal outbreaks, deliriums, hallucinations and alterations of sleeping patterns. Unbeatable profile of security and tolerance. Minimizes motor disorders. Reduces excessive sedation. Diminishes the anticholinergic effects. Re-establishes cognitive functions. Simple and flexible dosage. Only risperidone approved by the FDA. |